UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057419
Receipt number R000065607
Scientific Title Exploring Blood Biomarkers in patients with Hearing Loss
Date of disclosure of the study information 2025/03/27
Last modified on 2025/03/27 09:34:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploring Blood Biomarkers in patients with Hearing Loss

Acronym

Biomarkers of hearing loss

Scientific Title

Exploring Blood Biomarkers in patients with Hearing Loss

Scientific Title:Acronym

Exploring Biomarkers of Hearing Loss

Region

Japan


Condition

Condition

hearing loss, vertigo

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To perform blood tests in patients with inner ear disorders to search for causes and biomarkers.

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Correlation between hearing test (pure tone audiometry) and biomarkers

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification

YES

Dynamic allocation


Institution consideration


Blocking


Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Medicine

Interventions/Control_1

Blood test

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with inner ear disorders such as sudden hearing loss, Meniere's disease, presbycusis, vestibular neuritis, etc. who visit outpatient clinic in department of otorhinolaryngology in National institute of sensory organ Tokyo medical center

Key exclusion criteria

under 18 years of age, unconscious persons, etc.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name SHO
Middle name
Last name KANZAKI

Organization

National Institute of Sensory Organ, National Hospital Organization of Tokyo Medical Center

Division name

Laboratory of Auditory Disorders,Auditory and Balance Research Division

Zip code

152-8902

Address

2-5-1 Higashigaoka Meguro Tokyo, Japan

TEL

0334110111

Email

shokanza@yahoo.co.jp


Public contact

Name of contact person

1st name Sho
Middle name
Last name Kanzaki

Organization

National institute of Sensory Organ, National Hospital Organization of Tokyo Medical Center

Division name

Laboratory of Auditory Disorders, Auditory and Balance Research Division

Zip code

152-8902

Address

2-5-1 Higashigaoka Meguro Tokyo

TEL

0353633827

Homepage URL


Email

shokanza@yahoo.co.jp


Sponsor or person

Institute

National Institute of Sensory Organ, National Hospital Organization of Tokyo Medical Center Clinical Research Center

Institute

Department

Personal name



Funding Source

Organization

The Uehara memorial foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of National Hospital Organization Tokyo Medical Center

Address

2-5-1 Higashigaoka Meguro Tokyo

Tel

0334110111

Email

shokanza@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 03 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2024 Year 09 Month 25 Day

Date of IRB

2024 Year 09 Month 25 Day

Anticipated trial start date

2024 Year 09 Month 26 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 03 Month 27 Day

Last modified on

2025 Year 03 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065607